2025 FDLI Annual Conference

May 15–16, 2025   Washington, DC & Virtual Event

Just Announced:

Hear directly from Martin A. Makary, Commissioner of Food and Drugs, U.S. Food and Drug Administration.

Overview

Looking forward to seeing you at the 2025 FDLI Annual Conference, the premier event for the food and drug law community! Our conference provides a unique opportunity to delve into the complex legal, regulatory, compliance, and policy issues currently impacting FDA-regulated industry. Join experts from federal government, industry, the private bar, non-profit organizations, patient and consumer advocacy groups, consulting organizations, and academia as the FDLI community meets for the event of the year!
 
 

Conference Highlights:

  • Hear FDA’s strategic priorities directly from the FDA Commissioner and other key leaders within the agency and Health and Human Services
  • Join high-level colleagues in food and drug law to hear different viewpoints, shape policy, and advance understanding
  • Participate in over 30 sessions covering the latest in legal, regulatory, compliance, policy, marketing, and related issues to enjoy targeted for your key interests
  • Learn from more than 100 well-known officials and experts
  • Hear about the Top Cases in Food and Drug Law
  • Network and build relationships with seasoned legal, regulatory, compliance, policy, and government professionals

Register

Registration pricing through 5/7/2025

$2,199

Members

$2,599

Non-Members

Industry

$1,899

Members

$2,299

Non-Members

Government &
Association

$1,399

Members

$1,599

Non-Members

Public/Patient Org
& Academic

$499

Members

$599

Non-Members

Student

Free

Members

$599

Non-Members

Impacted by the FDA reduction in force? You may be eligible for a reduced registration rate. Click here to apply.

Sponsors

Sponsorship opportunities are available. Please let us know if you would like more information.

Premier

 

Diamond

 

Gold

 

Silver

 

Bronze

 

Exhibitor

 

 

Planning Committee

Co-Chairs

Stacy Cline Amin
Oracle

Lowell Zeta
Hogan Lovells US LLP

Committee Members

Laura Akowuah, HFP, FDA
Kalah Auchincloss, ELIQUENT Life Sciences
Jennifer Bragg, Latham & Watkins LLP
Shelby Buettner, Becton Dickinson (BD)
Andrea Ferrenz, Campbell Soup Company
Lewis Grossman, American University
Dorothy Hatsukami, University of Minnesota
Jeremiah Kelly, Venable LLP
Winston Kirton, BakerHostetler
Paige Magness, Altria Client Services LLC
Sharon Mayl, DLA Piper LLP (US)
Rachael Pontikes, Blank Rome LLP
Mimi Riley, University of Virginia
Schevon Salmon, K&L Gates LLP
Sarah Sorscher, Center for Science in the Public Interest
Sarah Stec, Johnson & Johnson
Stuart TenHoor, Stuart TenHoor Legal Search
Rachel Turow, Skadden, Arps, Slate, Meagher & Flom LLP
Jennifer Zachary, Merck & Co., Inc.
Jessica Zeller, Edwards Lifesciences LLC

Call for Proposals

FDLI and the Conference Planning Committee thank those who participated in the Call for Proposals this fall. The input received from industry stakeholders helps us plan a timely program. If you submitted a proposal, you will be notified of the status of your proposal in mid-February.